Invent Ventures, Inc. is a publicly-traded venture firm focused on building and developing new digital technology companies. Their investment portfolio spans web, mobile, and biotechnology sectors, with a particular emphasis on early-stage startups. The firm typically participates in seed funding rounds, supporting innovative businesses in their initial growth phases.

One of Invent Ventures' notable portfolio companies is Sanguine, a biotech firm that has raised $2 million in funding. As a venture builder, Invent Ventures likely provides hands-on support and resources to its portfolio companies, helping them navigate the challenges of early-stage growth. The firm's public status offers a unique opportunity for investors to participate in the venture capital market through a publicly-traded entity.